Mexico donates 35,000 doses of COVID vaccines to Jamaica

The Caribbean island - Jamaica has received a donation of 35,000 doses of the Oxford-AstraZeneca COVID-19 vaccines from Mexico on June 23 2021.

Jamaica: The Caribbean island – Jamaica has received a donation of 35,000 doses of the Oxford-AstraZeneca COVID-19 vaccines from Mexico on June 23 2021.

The Minister of Foreign Affairs and Foreign Trade – Kamina Johnson Smith, welcomed the donation of the COVID-19 vaccines and stated, “The donation of the coronavirus vaccines comes at a critical time and would be central to expanding our vaccination programme, which has been impacted by global vaccine supply constraints.”

The Foreign Minister further provided the information that Mexico is currently the Pro Tempore Presidency of the community of Latin American and Caribbean States – CELAC, and in that place, has donated supplies of COVID19 vaccines to other nations in the region.

She noted that Jamaica’s Ministry of Health and Wellness and the Secretariat of Health of Mexico had signed an agreement earlier this week to address Jamaica’s urgent need for the COVID-19 vaccines.

The Minister further reemphasised the commitment of Jamaica to strengthen the relationship with Mexico and noted that on March 18, 2021, both the nations had celebrated fifty-five years of the establishment of diplomatic relations.

Following the statement, she added that both the nations enjoy active participation at the bilateral, regional and multilateral levels in fields of cooperation such as – security, education, culture, trade, tourism and investment.

Minister Johnson Smith underlined the relations between two nations and stated that “The partnership also bears witness to the significance of South-South and regional cooperation during these very tough times.”

According to the statistics so far, a total of 163,209 individuals have received their first dose of the COVID-19 vaccine, which is around 5.5 per cent of the total population.

While 31,106 individuals have received their second dose of the novel coronavirus vaccine, which is around 1.1 per cent of the total population and fully vaccinated against the deadly mutant.